Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2190b64dc3f328c4dc055fefb4efd9c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8967d4109627f528b266616327ac8a90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84ed89d67b816d253ac3c66de6040430 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a2f3e49ef6b2201d6b700eeaa04ce39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49e348de849791ef4c491c53966c5b94 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
filingDate |
2019-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22e9794c099a9fe251187bb91bbbbfcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d7fcdf36ead8d27c876ad47701ddfd4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1a4accf23be2ce35797d176cd9db07c |
publicationDate |
2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2019241844-A1 |
titleOfInvention |
Methods and systems for assessing the risk of glaucoma |
abstract |
The present disclosure relates to methods and systems for assessing the risk of glaucoma in a subject. In certain embodiments, the present disclosure provide a method of assessing the risk of primary open angle glaucoma in a subject, the method comprises determining a risk score for primary open angle glaucoma in the subject on the basis of the genetic content of the subject at a plurality of selected genetic loci or markers and thereby assessing the risk of primary open angle glaucoma in the subject, wherein the selected genetic loci or markers comprise (i) genetic loci or markers having an association with glaucoma, and/or (ii) genetic loci or markers having an association with increased intraocular pressure, and/or (iii) genetic loci or markers having an association with an increased vertical cup to disk ratio, and/or (iv) genetic loci or markers having an association with a multi-trait test of glaucoma, intraocular pressure and vertical cup to disc ratio. Other embodiments are described. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2778966-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112941170-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021158589-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2777667-C1 |
priorityDate |
2018-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |